---
title: "新股孖展統計 | 6 月 23 日"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/290554616.md"
description: "海光芯正、白鴿在線、禮邦醫藥-B、真健康醫療-B、來福諧波、鱘龍科技、江西生物、安克創新正在招股中。截至 6 月 23 日，富途證券、輝立證券等券商為海光芯正借出 724.2 億港元，超購逾 471.96 倍；為白鴿在線借出 27.7 億港元，超購逾 39.95 倍；為禮邦醫藥-B 借出 320.43 億港元，超購逾 248.81 倍；為真健康醫療-B 借出 3.05 億港元，超購逾 5.32 倍；為來福諧波借出 9.2 億港元，超購逾 15.01 倍；為鱘龍科技借出 9.57 億港元，超購逾 6.76 倍；為江西生物借出 3.14 億港元，超購逾 5.62 倍；為安克創新借出 3.35 億港元，認購未足額。"
datetime: "2026-06-23T11:19:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290554616.md)
  - [en](https://longbridge.com/en/news/290554616.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290554616.md)
---

# 新股孖展統計 | 6 月 23 日

智通財經 APP 獲悉，海光芯正 (01191)、白鴿在線 (02672)、禮邦醫藥-B(09637)、真健康醫療-B(02697)、來福諧波 (03952)、鱘龍科技 (06715)、江西生物 (06915)、安克創新 (00668) 正在招股中。截至 6 月 23 日，富途證券、輝立證券等券商為海光芯正借出 724.2 億港元，超購逾 471.96 倍；為白鴿在線借出 27.7 億港元，超購逾 39.95 倍；為禮邦醫藥-B 借出 320.43 億港元，超購逾 248.81 倍；為真健康醫療-B 借出 3.05 億港元，超購逾 5.32 倍；為來福諧波借出 9.2 億港元，超購逾 15.01 倍；為鱘龍科技借出 9.57 億港元，超購逾 6.76 倍；為江西生物借出 3.14 億港元，超購逾 5.62 倍；為安克創新借出 3.35 億港元，認購未足額。

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212817736983.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212817736983.png")![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212869609672.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212869609672.png")

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212882204846.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212882204846.png")

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212897270134.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212897270134.png")

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212911665773.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212911665773.png")

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212928413270.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212928413270.png")

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212943655546.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212943655546.png")

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260623/1782212835459165.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1782212835459165.png")

### 相關股票

- [FUTU.US](https://longbridge.com/zh-HK/quote/FUTU.US.md)
- [01191.HK](https://longbridge.com/zh-HK/quote/01191.HK.md)
- [02672.HK](https://longbridge.com/zh-HK/quote/02672.HK.md)
- [300866.CN](https://longbridge.com/zh-HK/quote/300866.CN.md)
- [09637.HK](https://longbridge.com/zh-HK/quote/09637.HK.md)
- [FUTG.US](https://longbridge.com/zh-HK/quote/FUTG.US.md)
- [03588.HK](https://longbridge.com/zh-HK/quote/03588.HK.md)

## 相關資訊與研究

- [【新股 IPO】【暗盤/中籤結果】光電互連產品提供商海光芯正 (1191) 暗盤最多升 86.84%，一手賬面賺 4950 元](https://longbridge.com/zh-HK/news/290951661.md)
- [新股暗盤 | 禮邦醫藥-B 盤初漲 76.99% 一手賬面賺 1740 港元](https://longbridge.com/zh-HK/news/290935893.md)
- [【新股上市】白鴿在線發售價為每股 15.6 元](https://longbridge.com/zh-HK/news/290813944.md)
- [新股 IPO 丨江西生物今起招股 入場費 6596 元](https://longbridge.com/zh-HK/news/290366729.md)
- [江西生物集資 4.7 億 預告今年利潤大跌](https://longbridge.com/zh-HK/news/290366625.md)